Novozymes A/S

Novozymes A/S Operating Cash Flow

The Operating Cash Flow of Novozymes A/S (NSIS B.CO) as of Nov 5, 2026 is 1.02 B EUR. In the previous year, Operating Cash Flow was 556.09 M EUR — a change of 83.40% (higher).

Operating Cash Flow

1.02 BEUR

YoY

83.40%

Last updated:

Operating Cash Flow of Novozymes A/S is 2024 1.02 B EUR. Operating Cash Flow of Novozymes A/S was 2023 556.09 M EUR. It decreases by 83.40% higher compared to the previous year.

The Novozymes A/S Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2017
4.06 B EUR
Jan 1, 2018
3.68 B EUR
Jan 1, 2019
3.20 B EUR
Jan 1, 2020
4.36 B EUR
Jan 1, 2021
544.74 M EUR
Jan 1, 2022
536.54 M EUR
Jan 1, 2023
556.09 M EUR
Jan 1, 2024
1.02 B EUR
The Novozymes A/S Operating Cash Flow history
YEAROperating Cash FlowYoY
1.02 BEUR+83.40%
556.09 MEUR+3.64%
536.54 MEUR-1.50%
544.74 MEUR-87.49%
4.36 BEUR+36.26%
3.20 BEUR-13.13%
3.68 BEUR-9.45%
4.06 BEUR+5.81%
3.84 BEUR+15.00%
3.34 BEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novozymes A/S Stock analysis

What does Novozymes A/S do? Novozymes A/S is a leading company in the field of biocatalysis and microbial solutions. It was founded in Denmark in 1925 under the name Nordisk Insulinlaboratorium. In 2000, the company was renamed Novozymes A/S and became part of the globally operating Novo Group. Novozymes' business model is to optimize the use of biocatalysts, enzymes, and microorganisms to offer sustainable solutions for various industries. Biocatalysts are biological molecules that accelerate or enable chemical reactions. The company works closely with customers in agriculture, household, food and beverage, laundry and cleaning products, animal feed, bioenergy, and biopharmaceutical industries. Novozymes' offerings include various divisions. The largest is the enzymes division, which produces enzymes for various industries. Novozymes' enzymes are used in the food and beverage industry, pulp and paper industry, and bioenergy, among others. The microbial solutions division offers various microorganisms that can be used in the production of biogas, animal feed, or odor removal. Novozymes also has a bioagriculture division that develops solutions for sustainable agriculture. This includes disease- and pest-resistant bioseeds, as well as enhanced soil and plant care. The company also has a biopharmaceutical division that focuses on producing enzymes for disease treatment. An important goal of Novozymes is to promote sustainability and environmental protection. The company advocates for the use of renewable resources and energy-efficient processes. This is also reflected in their products, which contribute to optimizing agricultural processes and reducing greenhouse gas emissions, for example. One example of a Novozymes product is NovoGro, a biofertilizer for sustainable agriculture. NovoGro enhances nutrient uptake in plants and contributes to healthy soils. Another product is an enzyme blend called Novozyme 188, which is used in beer production to improve filtration. In summary, Novozymes A/S is a company specializing in biocatalysis and microbial solutions. The company works closely with customers from various industries to offer sustainable solutions and promote environmental protection. Novozymes has different divisions and offers solutions such as enzymes and microorganisms that can be used in the food and beverage industry, pulp and paper industry, bioenergy, biopharmaceuticals, and many other areas. With its commitment to sustainability and environmental protection, Novozymes contributes to shaping a better future. Novozymes A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novozymes A/S stock

Operating Cash Flow of Novozymes A/S is 1.02 B EUR in 2024.

Operating Cash Flow of Novozymes A/S changed from 556.09 M EUR to 1.02 B EUR, representing a 83.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Novozymes A/S since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Novozymes A/S historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Novozymes A/S

All Key Metrics — Novozymes A/S